| Primary Device ID | 00365649850035 |
| NIH Device Record Key | deb3c664-29a9-4a16-8813-38ea2ffe3bbb |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | Solesta® |
| Version Model Number | 1085003 |
| Company DUNS | 793108036 |
| Company Name | SALIX PHARMACEUTICALS, LTD. |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | true |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com | |
| Phone | 8005080024 |
| salix@medcomsol.com |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 00365649850035 [Primary] |
| GS1 | 10365649850032 [Package] Package: Transport box [32 Units] In Commercial Distribution |
| LNM | Agent, Bulking, Injectable For Gastro-Urology Use |
| Steralize Prior To Use | false |
| Device Is Sterile | true |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 3 |
| Public Version Date | 2018-07-06 |
| Device Publish Date | 2014-10-31 |
| 00365649850035 - Solesta® | 2018-07-06SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (eg. diet, fiber therapy, anti-motility medications). |
| 00365649850035 - Solesta® | 2018-07-06 SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative thera |
| 00365649922039 - Deflux® | 2018-07-06 Deflux® is a bulking agent indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV. |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SOLESTA 90465463 not registered Live/Pending |
Galderma Holding S.A. 2021-01-14 |
![]() SOLESTA 88090466 not registered Live/Pending |
Néstlé Skin Health S.A. 2018-08-23 |
![]() SOLESTA 78853445 3352167 Dead/Cancelled |
NESTLÃ SKIN HEALTH S.A. 2006-04-04 |